{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T20:47:33Z","timestamp":1772743653495,"version":"3.50.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1097\/ftd.0b013e318283eaf2","type":"journal-article","created":{"date-parts":[[2013,5,10]],"date-time":"2013-05-10T10:41:41Z","timestamp":1368182501000},"page":"345-351","source":"Crossref","is-referenced-by-count":39,"title":["Plasma, Oral Fluid, and Whole-Blood Distribution of Antipsychotics and Metabolites in Clinical Samples"],"prefix":"10.1097","volume":"35","author":[{"given":"Danielle S.","family":"Fisher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerrit I.","family":"van Schalkwyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soraya","family":"Seedat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah R.","family":"Curran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Flanagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-11-20210129","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/archdischild-2011-300054","article-title":"Review on the current use of antipsychotic drugs in children and adolescents.","volume":"96","author":"Almandil","year":"2011","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"R2-11-20210129","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/pds.3265","article-title":". Childhood predictors of antipsychotic use among young people in Finland.","volume":"21","author":"Gyllenberg","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R3-11-20210129","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.pedhc.2011.10.009","article-title":"Antipsychotic medication prescribing trends in children and adolescents.","volume":"26","author":"Harrison","year":"2012","journal-title":"J Pediatr Health Care"},{"key":"R4-11-20210129","doi-asserted-by":"crossref","first-page":"e771","DOI":"10.1542\/peds.2011-2158","article-title":". Antipsychotics for children and young adults: a comparative effectiveness review.","volume":"129","author":"Seida","year":"2012","journal-title":"Pediatrics"},{"key":"R5-11-20210129","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/FTD.0b013e31819f3328","article-title":". Pharmacokinetics and therapeutic drug monitoring of psychotropic drugs in pediatrics.","volume":"31","author":"Pichini","year":"2009","journal-title":"Ther Drug Monit"},{"key":"R6-11-20210129","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.clinthera.2007.07.026","article-title":". Plasma pharmacokinetic characteristics of risperidone and their relationship to saliva concentrations in children with psychiatric or neurodevelopmental disorders.","volume":"29","author":"Aman","year":"2007","journal-title":"Clin Ther"},{"key":"R7-11-20210129","first-page":"147","article-title":"Drug testing in oral fluid.","volume":"27","author":"Drummer","year":"2006","journal-title":"Clin Biochem Rev"},{"key":"R9-11-20210129","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.chroma.2003.10.138","article-title":". Quantification of risperidone and 9-hydroxyrisperidone in plasma and saliva from adult and paediatric patients by liquid chromatography-mass spectrometry.","volume":"1026","author":"Flarakos","year":"2004","journal-title":"J Chromatogr A"},{"key":"R12-11-20210129","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/bmc.1009","article-title":"The role of alternative specimens in toxicological analysis.","volume":"22","author":"Gallardo","year":"2008","journal-title":"Biomed Chromatogr"},{"key":"R13-11-20210129","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jpba.2008.01.033","article-title":". Evaluation of saliva collection devices for the analysis of steroids, peptides and therapeutic drugs.","volume":"47","author":"Groschl","year":"2008","journal-title":"J Pharm Biomed Anal"},{"key":"R15-11-20210129","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/clinchem\/23.2.157","article-title":". Use of saliva in therapeutic drug monitoring.","volume":"23","author":"Horning","year":"1977","journal-title":"Clin Chem"},{"key":"R16-11-20210129","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.forsciint.2011.02.022","article-title":". Assessment of the stability of 30 antipsychotic drugs in stored blood specimens.","volume":"215","author":"Saar","year":"2012","journal-title":"Forensic Sci Int"},{"key":"R17-11-20210129","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1365-2125.2003.01821.x","article-title":"Comparability of whole-blood and plasma clozapine and norclozapine concentrations.","volume":"56","author":"Flanagan","year":"2003","journal-title":"Br J Clin Pharmacol"},{"key":"R18-11-20210129","first-page":"556","article-title":"Comparing serum to saliva acetaminophen kinetics.","volume":"33","author":"Nemecek","year":"2011","journal-title":"Ther Drug Monit"},{"key":"R19-11-20210129","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/FTD.0b013e3182603f62","article-title":". Plasma concentrations of quetiapine, N-desalkylquetiapine, O-desalkylquetiapine, 7-hydroxyquetiapine, and quetiapine sulfoxide in relation to quetiapine dose, formulation, and other factors.","volume":"34","author":"Fisher","year":"2012","journal-title":"Ther Drug Monit"},{"key":"R20-11-20210129","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.talanta.2010.02.067","article-title":". Analysis of risperidone and its metabolite in plasma and saliva by LC with coulometric detection and a novel MEPS procedure.","volume":"81","author":"Saracino","year":"2010","journal-title":"Talanta"},{"key":"R21-11-20210129","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jchromb.2010.11.033","article-title":". Analysis of risperidone and 9-hydroxyrisperidone in human plasma, urine and saliva by MEPS-LC-UV.","volume":"879","author":"Mandrioli","year":"2011","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R22-11-20210129","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jpba.2008.05.024","article-title":". LC-MSMS method for the determination of nine antidepressants and some of their main metabolites in oral fluid and plasma. Study of correlation between venlafaxine concentrations in both matrices.","volume":"48","author":"de Castro","year":"2008","journal-title":"J Pharm Biomed Anal"},{"key":"R23-11-20210129","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/FTD.0b013e3181ae46ea","article-title":". Relationship between oral fluid and blood concentrations of drugs of abuse in drivers suspected of driving under the influence of drugs.","volume":"31","author":"Wille","year":"2009","journal-title":"Ther Drug Monit"},{"key":"R24-11-20210129","first-page":"2059","article-title":"DArienzo CJ, et al..","volume":"4","author":"Ji","year":"2012","journal-title":"What is next for dried blood spots Bioanalysis"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0b013e318283eaf2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:40:33Z","timestamp":1620952833000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201306000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0b013e318283eaf2","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}